These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28194882)

  • 41. The role of low-molecular-weight heparins in the management of unstable angina and non-ST-segment elevation myocardial infarction.
    Cohen M
    J Thromb Thrombolysis; 2001 Apr; 11(2):171-4. PubMed ID: 11406733
    [No Abstract]   [Full Text] [Related]  

  • 42. The emerging role of low-molecular-weight heparin in cardiovascular medicine.
    Hirsh J; Bates SM
    Prog Cardiovasc Dis; 2000; 42(4):235-46. PubMed ID: 10661777
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comments on the use of bemiparin in diabetic foot ulcers.
    Aragón-Sánchez J; Lázaro-Martínez JL
    Diabet Med; 2009 Jan; 26(1):110. PubMed ID: 19125772
    [No Abstract]   [Full Text] [Related]  

  • 44. Low-molecular-weight heparin use in special populations.
    Johnson PN; Smith KM
    Orthopedics; 2004 Dec; 27(12):1245-8. PubMed ID: 15633954
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A critical review of the efficacy and safety in the use of low-molecular-weight heparin in acute ST-elevation myocardial infarction: a Bayesan approach.
    Buccelletti E; Spadaccio C; Chello M; Marsiliani D; Carroccia A; Iacomini P; Calabrò G; Gentiloni Silveri N; Franceschi F
    Eur Rev Med Pharmacol Sci; 2011 Jun; 15(6):701-10. PubMed ID: 21796875
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Prevention and treatment of venous thromboembolism in patients with cancer].
    Struve S; Wendtner CM
    Dtsch Med Wochenschr; 2012 Oct; 137(40):2007-9. PubMed ID: 22987155
    [No Abstract]   [Full Text] [Related]  

  • 47. Randomized clinical trial comparing epidural anaesthesia and patient-controlled analgesia after laparoscopic segmental colectomy (Br J Surg 2003; 90: 1195-1199).
    Baca B; Gönenç M; Hamzaodlu I; Karahasanodlu T
    Br J Surg; 2004 Jan; 91(1):125; author reply 125. PubMed ID: 14716808
    [No Abstract]   [Full Text] [Related]  

  • 48. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis.
    Gould MK; Dembitzer AD; Sanders GD; Garber AM
    Ann Intern Med; 1999 May; 130(10):789-99. PubMed ID: 10366368
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Short-Term and Long-Term Safety and Efficacy of Treatment of Acute Ischemic Stroke with Low-Molecular-Weight Heparin: Meta-Analysis of 19 Randomized Controlled Trials.
    Ye Y; Zhou W; Cheng W; Liu Y; Chang R
    World Neurosurg; 2020 Sep; 141():e26-e41. PubMed ID: 32311555
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anticoagulation for people with cancer and central venous catheters.
    Akl EA; Ramly EP; Kahale LA; Yosuico VE; Barba M; Sperati F; Cook D; Schünemann H
    Cochrane Database Syst Rev; 2014 Oct; (10):CD006468. PubMed ID: 25318061
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischemic stroke (Cochrane review).
    Counsell C; Sandercock P
    Stroke; 2002 Jul; 33(7):1925-6. PubMed ID: 12105377
    [No Abstract]   [Full Text] [Related]  

  • 52. Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials.
    Alhazzani W; Lim W; Jaeschke RZ; Murad MH; Cade J; Cook DJ
    Crit Care Med; 2013 Sep; 41(9):2088-98. PubMed ID: 23782973
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Letter 1: meta-analysis of trials comparing ximelagatran with low molecular weight heparin for prevention of venous thromboembolism after major orthopaedic surgery (Br J Surg 2005; 92: 1335-1344).
    Wille-Jorgensen P
    Br J Surg; 2006 Mar; 93(3):374; author reply 375-6. PubMed ID: 16498577
    [No Abstract]   [Full Text] [Related]  

  • 54. Low molecular weight heparins in acute coronary syndrome.
    Creekmore F
    S D J Med; 2000 Jan; 53(1):21-3. PubMed ID: 10652862
    [No Abstract]   [Full Text] [Related]  

  • 55. Letter 3: meta-analysis of trials comparing ximelagatran with low molecular weight heparin for prevention of venous thromboembolism after major orthopaedic surgery (Br J Surg 2005; 92: 1335-1344).
    Agnelli G; Bergqvist D; Dahl O; Eriksson B; Rud Lassen M; Mouret P; Rosencher N
    Br J Surg; 2006 Mar; 93(3):375; author reply 375-6. PubMed ID: 16498579
    [No Abstract]   [Full Text] [Related]  

  • 56. Letter 2: meta-analysis of trials comparing ximelagatran with low molecular weight heparin for prevention of venous thromboembolism after major orthopaedic surgery (Br J Surg 2005; 92: 1335-1344).
    Tangelder MJ; Bylock A; Held P
    Br J Surg; 2006 Mar; 93(3):374-5; author reply 375-6. PubMed ID: 16498578
    [No Abstract]   [Full Text] [Related]  

  • 57. [Efficacy and safety of low molecular weight heparin in the treatment of pulmonary thromboembolism].
    Cereza G; Danés I
    Med Clin (Barc); 1999 Jun; 113(3):115-6. PubMed ID: 10464747
    [No Abstract]   [Full Text] [Related]  

  • 58. Low-molecular-weight heparin for the treatment of deep vein thrombosis.
    Thompson-Ford JK
    Pharmacotherapy; 1998; 18(4):748-58. PubMed ID: 9692649
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Guideline update. VTE disease: which agents, and when.
    Holten KB; Merok J
    J Fam Pract; 2009 Mar; 58(3):E1. PubMed ID: 19284934
    [No Abstract]   [Full Text] [Related]  

  • 60. [LMWH and UFH in direct comparison. Consent: CERTIFY].
    MMW Fortschr Med; 2007 May; 149(20):53. PubMed ID: 18051967
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.